Site Selection, Manufacturing & Long-Term Follow-Up: Looming Challenges For A Rescue Phase 1/2 Gene Therapy Trial
Source: Premier Research
By Naomi Kautz

In the following article we introduce a case study as a framework for exploring critical study design considerations of gene therapy trials and offering strategies for addressing those hurdles.
This case study is based on Premier Research’s work operationalizing a rescue Phase 1/2 gene therapy trial involving localized administration of gene therapy using specialized equipment. The study comprised two parts, the second of which includes a sham procedure (see Figure 1):
- Part A: A dose-escalation study consisting of three cohorts and dose levels, with safety reviews in between each dose
- Part B: Once an optimal dose is found, randomize study participants to either gene therapy or sham procedure with subsequent follow-up
VIEW THE CASE STUDY!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Clinical Leader? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Premier Research
This website uses cookies to ensure you get the best experience on our website. Learn more